Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Effects on survival: thermal ablation vs stereotactic radiation therapy for non-small cell lung cancer

Posted by on Jan 20, 2019 in Lung cancer | 0 comments

In a nutshell This article investigated the safety and effectiveness of thermal ablation (TA) compared to stereotactic radiation therapy (SRT) for the treatment of non-small-cell lung cancer (NSCLC). The authors concluded that both thermal ablation and stereotactic radiation are safe and can improve survival of these patients. Some...

Read More

Is the biosimilar drug ABP 125 as effective as bevacizumab in patients with lung cancer?

Posted by on Jan 17, 2019 in Lung cancer | 0 comments

In a nutshell This study examined how safe and effective is biosimilar ABP 215 in non-small cell lung cancer (NSCLC), compared to bevacizumab (Avastin). This study concluded that this drug is as safe and effective as bevacizumab in these patients. Some background Non-small cell lung cancer (NSCLC) is the most common type of lung...

Read More

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.

Posted by on Jan 12, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if the medication brigatinib (Alunbrig) is better than crizotinib (Xalkori) in treating patients with lung cancer. The study found that survival was significantly longer in patients who were treated with brigatinib compared to those treated with crizotinib. Some background Brigatinib and crizotinib are a...

Read More

Alectinib vs crizotinib in treating brain or spinal cord tumors in patients with non-small cell lung cancer

Posted by on Jan 12, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out which medication is better for treating lung cancer that has spread to the brain or spinal cord, crizotinib (Xalkori) or alectinib (Alecensa). The study found that alectinib worked better than crizotinib for treatment of tumors of the brain and spinal cord. Some background Alectinib and crizotinib are two...

Read More

Treating non-small cell lung cancers that have spread.

Posted by on Dec 11, 2018 in Lung cancer | 0 comments

In a nutshell This paper is about how to diagnose, treat, and follow up on non-small cell lung cancer cases that have spread through the body. The paper overall noted that non-small cell lung cancer which has spread is often very aggressive and hard to treat, and that methods of treatment are still being developed.   Some background Non-small...

Read More

Erlotinib in patients with non-small cell lung cancer

Posted by on Dec 11, 2018 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if using the medication erlotinib (Tarceva) in patients with non-small cell lung cancer improved survival. The study found that using erlotinib was safe, and may reduce the need for radical surgery in patients with non-small cell lung cancer. Some background Epidermal growth factor receptor (EGFR) is...

Read More

Adding local therapy to EGFR inhibitor treatment for lung cancer that has spread to the liver

Posted by on Nov 24, 2018 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if adding extra treatment targeted to the liver alongside treatment with EGFR inhibitors helped in patients with lung cancer that had spread to the liver. The study found that adding the extra treatment meant the patients survived longer compared to treatment with EGFR inhibitors alone. Some background...

Read More